Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Wolf

Showing results (21-30 of 330) with videos related to

Pageof 33
Sort By:
The Oncologist|August 4, 2016
Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open QuestionsMaximilian Boesch, Sieghart Sopper, Dominik Wolf
The New England Journal of Medicine|February 10, 2021
Atezolizumab for PD-L1-Selected Patients with NSCLCAndreas Pircher, Isabel Heidegger, Dominik Wolf
Oncoimmunology|May 7, 2014
Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioningDominik Wolf, Annkristin Heine, Peter Brossart
The Journal of Clinical Investigation|March 1, 2024
The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapiesDominik Wolf, Stefan Salcher, Andreas Pircher
Oncoscience|October 2, 2015
NK cell modulation by JAK inhibitionKathrin Schönberg, Janna Rudolph, Dominik Wolf
Molecular Therapy. Oncology|April 20, 2026
NR2F6-modified CAR T cells drive extrinsic immunogenic cell death and antigen-agnostic immunity in solid tumorsVictoria Klepsch, Dominik Wolf, Gottfried Baier
Leukemia & Lymphoma|April 10, 2008
Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemiaStefan Schmidt, Guenther Gastl, Dominik Wolf
Blood|November 30, 2013
Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?Annkristin Heine, Peter Brossart, Dominik Wolf
Stem Cells International|January 23, 2016
Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population PhenotypeMaximilian Boesch, Dominik Wolf, Sieghart Sopper
The New England Journal of Medicine|March 26, 2015
More on remission of recalcitrant dermatomyositis treated with ruxolitinibThorsten Hornung, Dominik Wolf, Joerg Wenzel
Pageof 33

Showing results (21-30 of 330) with videos related to

Sort By:
Pageof 33
The Oncologist|August 4, 2016
Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open QuestionsMaximilian Boesch, Sieghart Sopper, Dominik Wolf
The New England Journal of Medicine|February 10, 2021
Atezolizumab for PD-L1-Selected Patients with NSCLCAndreas Pircher, Isabel Heidegger, Dominik Wolf
Oncoimmunology|May 7, 2014
Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioningDominik Wolf, Annkristin Heine, Peter Brossart
The Journal of Clinical Investigation|March 1, 2024
The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapiesDominik Wolf, Stefan Salcher, Andreas Pircher
Oncoscience|October 2, 2015
NK cell modulation by JAK inhibitionKathrin Schönberg, Janna Rudolph, Dominik Wolf
Molecular Therapy. Oncology|April 20, 2026
NR2F6-modified CAR T cells drive extrinsic immunogenic cell death and antigen-agnostic immunity in solid tumorsVictoria Klepsch, Dominik Wolf, Gottfried Baier
Leukemia & Lymphoma|April 10, 2008
Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemiaStefan Schmidt, Guenther Gastl, Dominik Wolf
Blood|November 30, 2013
Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?Annkristin Heine, Peter Brossart, Dominik Wolf
Stem Cells International|January 23, 2016
Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population PhenotypeMaximilian Boesch, Dominik Wolf, Sieghart Sopper
The New England Journal of Medicine|March 26, 2015
More on remission of recalcitrant dermatomyositis treated with ruxolitinibThorsten Hornung, Dominik Wolf, Joerg Wenzel
Pageof 33